Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Anti-depressant stories

Oct 30, 2026

EMA reviews Lundbeck's Deanxit after reports of serious neurological side effects

The European Medicines Agency has begun a safety review of Deanxit, a depression and anxiety medication made by Danish drugmaker H Lundbeck, following reports of serious neurological and psychiatric side effects.

Oct 30, 2026·2 sources
00
Jul 18, 2026

Fluvoxamine shows promise for long COVID fatigue in clinical trial

A randomized clinical trial of 399 adults found that the low-cost antidepressant fluvoxamine significantly reduced fatigue and improved quality of life in people struggling with long COVID symptoms.

Jul 18, 2026·1 source
00

Top claims

  • ▪Danish drugmaker H Lundbeck declined to comment on the European Medicines Agency's safety review of Deanxit.
  • ▪Belgium's medicines agency raised concerns about the long-term use of Deanxit, noting that flupentixol has been linked to potentially irreversible serious side effects.
  • ▪The European Medicines Agency's Pharmacovigilance Risk Assessment Committee will evaluate Deanxit data to decide whether to retain, amend, suspend, or revoke the drug's marketing authorization, with the review expected to conclude by March.

Subtopics

Drug Policy, Pricing & Approval2Adverse event reporting (FAERS)1Anxiety and depression1Clinical evaluation1Clinical Trial Design & Evaluation1Clinical trials1Drug Approval and Clinical Trials1Drug safety & pharmacovigilance1Infectious Disease and Outbreaks1Long COVID1Mental Health & Wellbeing1Neurological disorders1Pharmaceutical Industry1Public Health and Safety1Public healthcare1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories